Literature DB >> 22155912

IL28B CC-genotype association with HLA-DQB1*0301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients.

Alessandra Mangia1, Rosanna Santoro, Roberto Sarli, Leonardo Mottola, Valeria Piazzolla, Daniela Petruzzellis, Donato Bacca, Rocco Clemente, Massimiliano Copetti, Lazzaro di Mauro, Giuseppe Lotti, Michele Sacco, Ippazio Stefano.   

Abstract

BACKGROUND: A single nucleotide polymorphism (SNP), upstream of the IL28B gene has been recently associated with natural clearance of HCV. In a well-characterized cohort of patients with thalassaemia major exposed to the risk of acquiring HCV infection by blood transfusions, we aimed to replicate this finding and to evaluate whether combining the IL28B genotype and HLA class II alleles allow viral clearance to be accurately predicted.
METHODS: Of 168 patients, 130 with complete clinical history were included in the analysis. According with their HCV antibodies status 13 were defined HCV resistant, and 117 infected. Infected patients were subdivided, giving 49 with self-limiting and 68 with ongoing infection.
RESULTS: IL28B CC-genotype was observed in 32 patients with self-limiting and in 23 with ongoing infection (64% versus 34%; P=0.004). HLA DQB1*0301 allele was associated with viral clearance in 36 cases (73%; P<0.0001). Both DQB1*0301 and IL28B CC-genotype were found to be independent predictors of HCV clearance (OR=5.64, 95% CI 1.52-20.9 and OR=5.76, 95% CI 2.16-15.33, respectively). With the addition of DQB1*0301, the accuracy of the prediction increased from 63% to 69%.
CONCLUSIONS: In addition to IL28B CC-genotype, HLA DQB1*0301 helps in predicting natural clearance of HCV after acute infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155912     DOI: 10.3851/IMP1913

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  8 in total

Review 1.  Acute hepatitis C: management in the rapidly evolving world of HCV.

Authors:  Suraj A Sharma; Jordan J Feld
Journal:  Curr Gastroenterol Rep       Date:  2014-02

2.  Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.

Authors:  María A Jiménez-Sousa; Amanda Fernández-Rodríguez; María Guzmán-Fulgencio; Mónica García-Álvarez; Salvador Resino
Journal:  BMC Med       Date:  2013-01-08       Impact factor: 8.775

3.  Serologic evaluation of celiac disease in patients with beta thalassemia major and control.

Authors:  Iraj Shahramian; Seyed Mohsen Dehghani; Mahmood Haghighat; Noor Mohammad Noori; Ali Reza Teimouri; Elham Sharafi; Manijeh Kalili
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

Review 4.  Footprint of the COVID-19 Pandemic in India: A Study of Immune Landscape and Other Factors Shielding Mortality.

Authors:  Noura Al-Dayan; Divya Venugopal; Sugapriya Dhanasekaran
Journal:  Anal Cell Pathol (Amst)       Date:  2020-12-24       Impact factor: 2.916

5.  Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.

Authors:  Karen Fitzmaurice; Jacob Hurst; Megan Dring; Andri Rauch; Paul J McLaren; Huldrych F Günthard; Clair Gardiner; Paul Klenerman
Journal:  Gut       Date:  2014-07-04       Impact factor: 23.059

6.  The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population.

Authors:  Jieting Huang; Ke Huang; Ru Xu; Min Wang; Qiao Liao; Huaping Xiong; Chengyao Li; Xi Tang; Zhengang Shan; Ming Zhang; Xia Rong; Kenrad Nelson; Yongshui Fu
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

7.  HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance.

Authors:  Mario Frias; Antonio Rivero-Juárez; Diego Rodriguez-Cano; Ángela Camacho; Pedro López-López; María Ángeles Risalde; Bárbara Manzanares-Martín; Teresa Brieva; Isabel Machuca; Antonio Rivero
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

Review 8.  Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence.

Authors:  Alessandra Mangia; Davide Bellini; Umberto Cillo; Andrea Laghi; Giuseppe Pelle; Vanna Maria Valori; Eugenio Caturelli
Journal:  BMC Gastroenterol       Date:  2020-08-03       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.